U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C5H5N5.H2O4S
Molecular Weight 368.332
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADENINE SULFATE

SMILES

OS(O)(=O)=O.NC1=C2N=CNC2=NC=N1.NC3=C4N=CNC4=NC=N3

InChI

InChIKey=LQXHSCOPYJCOMD-UHFFFAOYSA-N
InChI=1S/2C5H5N5.H2O4S/c2*6-4-3-5(9-1-7-3)10-2-8-4;1-5(2,3)4/h2*1-2H,(H3,6,7,8,9,10);(H2,1,2,3,4)

HIDE SMILES / InChI

Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C5H5N5
Molecular Weight 135.1267
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842

Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
85.8 µM [Ki]
200.0 µM [IC50]
10.89 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
LEUKOTRAP WB SYSTEM

Approved Use

Indicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product.
Secondary
Unknown

Approved Use

Unknown
Secondary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
6.8 μM
27 μmol/kg single, oral
dose: 27 μmol/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
ADENINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency.
2001-04
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms.
2001-03-16
Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.
2001-03-15
Role of adenosine kinase in Saccharomyces cerevisiae: identification of the ADO1 gene and study of the mutant phenotypes.
2001-03-15
Expression and mutagenesis of the NqrC subunit of the NQR respiratory Na(+) pump from Vibrio cholerae with covalently attached FMN.
2001-03-09
Solution structure of an A-tract DNA bend.
2001-03-09
Regulation of protein degradation and protease expression by mannose in maize root tips. Pi sequestration by mannose may hinder the study of its signaling properties.
2001-03
2,8-Dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT.
2001-03
Escherichia coli FtsH (HflB) degrades a membrane-associated TolAI-II-beta-lactamase fusion protein under highly denaturing conditions.
2001-03
Successful nonfreezing, subzero preservation of rat liver with 2,3-butanediol and type I antifreeze protein.
2001-03
Signaling pathways involved in the A and B receptor-mediated cortisol secretagogue effect of endothelins in the human adrenal cortex.
2001-03
Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women.
2001-03
Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals.
2001-03
Adenosine signaling in outer medullary descending vasa recta.
2001-03
cAMP-independent phosphorylation activation of CFTR by G proteins in native human sweat duct.
2001-03
Adenosine increases ventilation rate, cardiac performance and haemolymph velocity in the American lobster Homarus americanus.
2001-03
Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells.
2001-02-23
Anatomy of a preferred target site for the bacterial insertion sequence IS903.
2001-02-23
Cloning, sequence analysis and heterologous expression of the DNA adenine-(N(6)) methyltransferase from the human pathogen Actinobacillus actinomycetemcomitans.
2001-02-20
Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target.
2001-02-15
"Chemical preconditioning" by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs.
2001-02-15
In situ kinetic characterization of methylthioadenosine transport by the adenosine transporter (P2) of the African Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
2001-02-15
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717.
2001-02-15
Thermodynamics of ion-induced RNA folding in the hammerhead ribozyme: an isothermal titration calorimetric study.
2001-02-06
FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
2001-02-06
Phosphorescence and optically detected magnetic resonance of HIV-1 nucleocapsid protein complexes with stem-loop sequences of the genomic Psi-recognition element.
2001-02-06
Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
2001-02-06
Quantum-chemical analysis of C-H...O and C-H...N interactions in RNA base pairs--H-bond versus anti-H-bond pattern.
2001-02
Mechanisms and modulation of intestinal epithelial repair.
2001-02
NO Inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase.
2001-02
Renal interstitial adenosine metabolism during ischemia in dogs.
2001-02
Inhibition of human squalene monooxygenase by tellurium compounds: evidence of interaction with vicinal sulfhydryls.
2001-02
Structure of the N6-adenine DNA methyltransferase M.TaqI in complex with DNA and a cofactor analog.
2001-02
Structure of the electron transfer complex between ferredoxin and ferredoxin-NADP(+) reductase.
2001-02
A Taq attack displaces bases.
2001-02
Crystallization and preliminary X-ray analysis of a DNA dodecamer containing 2'-deoxy-5-formyluridine; what is the role of magnesium cation in crystallization of Dickerson-type DNA dodecamers?
2001-02
Minor groove functional groups are critical for the B-form conformation of duplex DNA.
2001-01-30
Conformation and dynamics of abasic sites in DNA investigated by time-resolved fluorescence of 2-aminopurine.
2001-01-30
Codon bias at the 3'-side of the initiation codon is correlated with translation initiation efficiency in Escherichia coli.
2001-01-24
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
2001-01-18
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.
2001-01-15
Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta.
2001-01
Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.
2001-01
Quantum chemistry predicted correlations between geometric isomerism (conformation) of -OH and =NH substituents and typical group frequencies of nucleic acid bases: cytosine.
2001-01
An electrochemical evidence of free radicals formation from flutamide and its reactivity with endo/xenobiotics of pharmacological relevance.
2001-01
Adenine and guanine nucleotide-specific succinyl-CoA synthetases in the clonal beta-cell mitochondria: implications in the beta-cell high-energy phosphate metabolism in relation to physiological insulin secretion.
2001-01
Side chain-dependent binding of antitumor indoloquinoxaline derivatives to DNA: comparative spectroscopic and viscometric measurements.
2001-01
Influence of a probiotic yoghurt on the status of vitamins B(1), B(2) and B(6) in the healthy adult human.
2001
Capillary affinity gel electrophoresis.
2001
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals.
2001
Patents

Sample Use Guides

the daily dose of adenine is 10-60 mg/day
Route of Administration: Oral
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:48:13 GMT 2025
Edited
by admin
on Mon Mar 31 17:48:13 GMT 2025
Record UNII
741GJF3K9M
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
6-AMINOPURINE HEMISULFATE SALT
Preferred Name English
ADENINE SULFATE
Common Name English
ADENINE HEMISULFATE SALT
Common Name English
Code System Code Type Description
FDA UNII
741GJF3K9M
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
CAS
321-30-2
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
EPA CompTox
DTXSID50883360
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-286-5
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
PUBCHEM
9449
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
DRUG BANK
DBSALT002226
Created by admin on Mon Mar 31 17:48:13 GMT 2025 , Edited by admin on Mon Mar 31 17:48:13 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE